운동이 전립선 비대 유도 마우스의 혈중 염증반응 지표 및 전립선 조직의 IL-6, NF-kb, COX-2 mRNA 발현에 미치는 영향

키워드

참고문헌 (44)

1. Wolin KY, "Risk of urinary incontinence following prostatectomy : the role of physical activity and obesity", J Urol, 183(2), pp.629~633 (2010)
2. Karunasagara S, "Protective effects of combination of stauntonia hexaphylla and cornus officinalis on testosterone-induced benign prostatic hyperplasia through inhibition of 5alpha-reductase type 2 and induced cell apoptosis", PLoS One, 15(8), pp.e0236879~ (2020)
3. Da Silva MHA, "Current evidence for the involvement of sex steroid receptors and sex hormones in benign prostatic hyperplasia", Res Rep Urol, 11, pp.1~8 (2019)
4. Calogero AE, "Epidemiology and risk factors of lower urinary tract symptoms", benign prostatic hyperplasia and erectile dysfunction, 2019, pp.22(1), 12~19
5. Madersbacher S, "Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement : a mini-review", Gerontology, 65(5), pp.458~464 (2019)
6. He Q, "Metabolic syndrome, inflammation and lower urinary tract symptoms : possible translational links", Prostate Cancer Prostatic Dis, 19(1), pp.7~13 (2016)
7. De Nunzio C, "Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia", World J Urol, 38(11), pp.2771~2779 (2020)
8. Sarma AV, "Diabetes and benign prostatic hyperplasia : emerging clinical connections", Curr Urol Rep, 10(4), pp.267~275 (2009)
9. Kruslin B, "Inflammation in prostatic hyperplasia and carcinoma-basic scientific approach", Front Oncol, 7, pp.77~ (2017)
10. Schenk JM, "Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia : results from the prostate cancer prevention trial", Am J Epidemiol, 171(5), pp.571~582 (2010)
11. Nunez C, "TNF", IL-1, NF-kappa B transduction pathway : a comparative study in normal and pathological human prostate(benign hyperplasia and carcinoma), pp.Histopathology, 2008[DOI]
12. Atawia RT, "Modulatory effect of silymarin on inflammatory mediators in experimentally induced benign prostatic hyperplasia : emphasis on PTEN, HIF-1alpha, and NF-kappaB", Naunyn Schmiedebergs Arch Pharmacol, 387(12), pp.1131~1140 (2014)
13. Penna G, "Human benign prostatic hyperplasia stromal cells as inducers and targets of chronic immuno-mediated inflammation", J Immunol, 182(7), pp.4056~4064 (2009)
14. Minutoli L, "Serenoa Repens, lycopene and selenium : a triple therapeutic approach to manage benign prostatic hyperplasia", Curr Med Chem, 20(10), pp.1306~1312 (2013)
15. De Nunzio C, "The controversial relationship between benign prostatic hyperplasia and prostate cancer : the role of inflammation", Eur Urol, 60(1), pp.106~117 (2011)
16. Bostanci Y, "Correlation between benign prostatic hyperplasia and inflammation", Curr Opin Urol, 23(1), pp.5~10 (2013)
17. St Sauver JL, "Protective association between nonsteroidal antiinflammatory drug use and measures of benign prostatic hyperplasia", Am J Epidemiol, 164(8), pp.760~768 (2006)
18. St Sauver JL, "Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms", BJU Int, 107(3), pp.443~450 (2011)
19. Parsons JK, "Lifestyle factors, benign prostatic hyperplasia, and lower urinary tract symptoms", Curr Opin Urol, 21(1), pp.1~4 (2011)
20. Parsons JK, "Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms : new approaches to old problems", J Urol, 178(2), pp.395~401 (2007)
21. Parsons JK, "Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms", Eur Urol, 53(6), pp.1228~1235 (2008)
22. Wolin KY, "Physical activity and benign prostatic hyperplasia-related outcomes and nocturia", Med Sci Sports Exerc, 47(3), pp.581~592 (2015)
23. Wang SS, "Aerobic exercise ameliorates benign prostatic hyperplasia in obese mice through downregulating the AR", androgen, AKT signaling pathway, pp.Exp Gerontol, 2021[DOI]
24. Nian L, "Aerobic exercises ameliorate benign prostatic hyperplasia via IGF-1", IGF-1R, AKT signalling pathway in prostate tissue of high-fat-diet-fed mice with insulin resistance, pp.Steroids, 2021[DOI]
25. Cegiela U, "Exercise prevented the lansoprazole-induced reduction of anti-osteoporotic efficacy of alendronate in androgen deficiency rats", Acta Pol Pharm, 71(3), pp.485~495 (2014)
26. Vendramini-Costa DB, "Molecular link mechanisms between inflammation and cancer", Curr Pharm Des, 18(26), pp.3831~3852 (2012)
27. De Nunzio C, "Inflammatory mediators in the development and progression of benign prostatic hyperplasia", Nat Rev Urol, 13(10), pp.613~626 (2016)
28. Jin BR, "Carica papaya leaf extract inhibits prostatitis-associated prostatic hyperplasia via the TRAF6", TAK1, NF-kappaB pathway, pp.Biomed Pharmacother, 2021[DOI]
29. Wang X, "Increased infiltrated macrophages in benign prostatic hyperplasia(BPH) : role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferation", J Biol Chem, 287(22), pp.18376~18385 (2012)
30. Dang T, "Macrophage cytokines Enhance cell proliferation of normal prostate epithelial cells through activation of ERK and akt", Sci Rep, 8(1), pp.7718~ (2018)
31. Gandaglia G, "The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia(BPH)", BJU Int, 112(4), pp.432~441 (2013)
32. de Lemos ET, "Regular physical exercise as a strategy to improve antioxidant and anti-inflammatory status : benefits in type 2 diabetes mellitus", Oxid Med Cell Longev, 2012, pp.741545~ (2012)
33. Chen KC, "Benign prostatic hyperplasia complicated with T1DM can be alleviated by treadmill exercise-evidences revealed by the rat model", BMC Urol, 15, pp.113~ (2015)
34. Peng CC, "Action mechanism of ginkgo biloba leaf extract intervened by exercise therapy in treatment of benign prostate hyperplasia", Evid Based Complement Alternat Med, 2013, pp.408734~ (2013)
35. Williams PT, "Effects of running distance and performance on incident benign prostatic hyperplasia", Med Sci Sports Exerc, 40(10), pp.1733~1739 (2008)
36. Wang S, "Curcuma oil ameliorates benign prostatic hyperplasia through suppression of the nuclear factorkappa B signaling pathway in rats", J Ethnopharmacol, 279, pp.113703~ (2020)
37. Wang W, "Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium", Prostate, 61(1), pp.60~72 (2004)
38. Roumeguere T, "Oxidative stress and prostatic diseases", Mol Clin Oncol, 7(5), pp.723~728 (2017)
39. Aryal M, "Oxidative stress in benign prostate hyperplasia", Nepal Med Coll J, 9(4), pp.222~224 (2007)
40. Arsova-Sarafinovska Z, "Increased oxidative", nitrosative stress and decreased antioxidant enzyme activities in prostate cancer, 2009, pp.42(12), 1228~1235
41. Zhao X, "Effects of moderate exercise over different phases on age-related physiological dysfunction in testes of SAMP8 mice", Exp Gerontol, 48(9), pp.869~880 (2013)
42. Paterniti I, "Effects of different natural extracts in an experimental model of benign prostatic hyperplasia(BPH)", Inflamm Res, 67(7), pp.617~626 (2018)
43. Akanni OO, "Protocatechuic acid ameliorates testosterone-induced benign prostatic hyperplasia through the regulation of inflammation and oxidative stress in castrated rats", J Biochem Mol Toxicol, 34(8), pp.e22502~ (2020)
44. Hayes BD, "Exercise and prostate cancer : evidence and proposed mechanisms for disease modification", Cancer Epidemiol Biomarkers Prev, 25(9), pp.1281~1288 (2016)

관련 논문AI추천